-
Incurable breast cancer numbers almost triple previous estimates. World first data
After 25 years of advocacy by BCNA, people with metastatic breast cancer (MBC) have finally been counted — at least in New South Wales. In a data breakthrough that far surpasses previous estimates, the Cancer Institute NSW has identified there are 7900 (7850 women and 50 men) living with MBC in NSW alone. This world-first…
-
BCNA statement about Elle Macpherson's treatment decisions
Breast Cancer Network Australia (BCNA) would like to address recent media coverage regarding Elle Macpherson's statements about her personal approach to breast cancer treatment. Elle Macpherson's choices highlight the deeply personal nature of treatment decisions following a breast cancer diagnosis. BCNA respects Elle…
-
Enhertu for people living with HER2-low metastatic breast cancer
We have some amazing news to share with our network today, following an announcement this morning from the Australian Government. People living with HER2-low metastatic breast cancer will, from 1 September 2024, have access to the life-prolonging drug Enhertu (trastuzumab deruxtecan) through the Pharmaceutical Benefits…
-
Supporting you through the current media coverage
Good morning all, As we’ve seen unfold in discussions over the past week in the online network, many of you have been impacted by the media surrounding a celebrity’s choices during their own cancer treatment. This is not the first time, nor the last, that a high-profile person will make statements that can affect those of…
-
Friday Update - 6th September 2024
Hello members,
we’re pleased to bring you the latest Friday Update from our forum. Dive in to
catch up on what’s been happening around Breast Cancer Network Australia (BCNA)
and see what your fellow members have been chatting about. As I was
looking into Spring news and tips, I came across interesting insight from…
-
Friday Update (On Tuesday!) - 13th August 2024
Hello everyone, We’re excited to bring you the latest updates, tips, and highlights from our community. Whether you’re a long-time member or new to our forum, we hope you find this update both informative and engaging. Thank you for being a part of our community. Community Highlights July Activity July saw 113 new members;…
-
Friday Update - 12th July 2024
Welcome to the latest Friday Update! This week is NAIDOC week (National Aboriginal and Islanders Day Observance Committee) and celebrates the history, culture and achievements of Aboriginal and Torres Strait Islander peoples. Therefore we will again highlight BCNA's information and support for our First Peoples. Last month…
-
BCNA Leads First National Roadmap to Collecting Metastatic Breast Cancer Data
A roadmap to finally count the number of people diagnosed with incurable and life limiting metastatic breast cancer (MBC) is a step closer thanks to the $1.5 million announced over the weekend by Prime Minister Anthony Albanese to fund a cancer data alliance. Almost two years ago a group of Breast Cancer Network Australia…
-
Friday Update (On Tuesday!) - 18th June 2024
Hello members new, old and in between :) Well, it has been some time since I crammed in an update for you all (apologies) and Tuesday is just as good a day as any right? During the month of May BCNA had another very successful Pink Bun campaign and our webcast 'Let's cut through all the hype! Why exercise?' was a hit! As…
-
Olaparib (Lynparza) for metastatic breast cancer in people with a BRCA gene mutation
Urgent opportunity As some of you may know, BCNA provides a
consumer comment to the Pharmaceutical Benefits Advisory Committee (PBAC) in
support of drugs being considered for subsidy on the PBS. Equity of access to
new treatment options is especially important for those with metastatic breast
cancer. Our policy team are…
-
BCNA welcomes pharmacy prescription changes for breast cancer medications
Six key breast cancer drugs are now more affordable thanks to 60-day prescribing. BCNA is pleased to confirm that six common types of hormone blocking therapies such as letrozole, anastrozole and tamoxifen, amongst others, are now able to be prescribed 60-days at a time, saving consumers time and money. “It is especially…
-
Lancet Breast Cancer Commission
A landmark report by The Lancet Breast Cancer Commission has highlighted gross inequities in breast cancer care in both low and high-income countries globally. “Many groups are being systemically left behind, ignored or forgotten” - Professor Charlotte Coles, Chair of the Lancet Commission. People living with metastatic…